ENDEFR
Home › Czechia › Takeda Pharmaceuticals Czech Republic s.r.o

Takeda Pharmaceuticals Czech Republic s.r.o

Společnost s ručením omezeným · Praha, Czechia · LEI 254900G1OYYN1PMAKS83
LEI active

Summary

Takeda Pharmaceuticals Czech Republic s.r.o is registered in Czechia and entered in the “Commercial Register (Obchodní rejstřík)” under number 60469803. Its legal form is Společnost s ručením omezeným – private limited company (Czechia). According to GLEIF, its ultimate parent is 武田薬品工業株式会社 (Japan), which is also its direct parent. That group has 11 subsidiaries with LEIs in 9 countries, 1 of them in Czechia. The LEI was first issued on 19 Dec 2025 and the record was last updated on 19 Dec 2025; the next renewal is due by 19 Dec 2026.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formSpolečnost s ručením omezeným
private limited company (Czechia)
RegisterCommercial Register (Obchodní rejstřík) · Register website
Registration number60469803
Registration authorityMinistry of Justice
JurisdictionCzechia
Registered addressSkretova 490/12, Vinohrady, 120 00 Praha, Czechia
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)5 Jan 1994
LEI254900G1OYYN1PMAKS83
LEI statusactive
LEI first issued19 Dec 2025
LEI record last updated19 Dec 2025
Next LEI renewal19 Dec 2026
Corroboration of the LEI recordfully corroborated

Group membership

武田薬品工業株式会社 Japan ultimate parent
Takeda Pharmaceuticals Czech Republic s.r.o this entity
View the whole group: 11 subsidiaries in 9 countries

Relationship to the parent

Direct parentUltimate parent
Parent武田薬品工業株式会社武田薬品工業株式会社
Accounting period8 Dec 2025 to 7 Dec 20268 Dec 2025 to 7 Dec 2026
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Accounting standardother standardother standard
Relationship start8 Dec 20258 Dec 2025
Recorded at GLEIF since19 Dec 202519 Dec 2025
Last updated19 Dec 202519 Dec 2025
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (7)